AwardTape · Defense awards · Zymeron Corporation
Zymeron Corporation: $3.7M in DoD and DHS awards
Zymeron Corporation holds 7 DoD and DHS prime awards with $3.7M obligated Oct 4, 2023 to May 21, 2026. Largest category: Health R&D at $3.5M; largest buyer: Defense Health Agency at $3.5M.
| Obligated FY2024+ | $3.7M |
|---|---|
| Awards | 7 |
| FY2024 | $3.7M |
| FY2025 | $0 |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $9.9M |
| First and latest action | Oct 4, 2023 · May 21, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Health R&D | $3.5M | 6 awards | 95% |
| 2 | Science and technology R&D | $197K | 1 awards | 5.3% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $3.5M | 6 awards | 95% |
| 2 | Department of the Army | $197K | 1 awards | 5.3% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT942524C0057 definitive contract | $3.0M | Dha sbir direct phase ii h2d-0243 rapid sample processing device to support battlefield wound infection diagnostics | Defense Health Agency | Health R&D | May 21, 2026 DoD 90d |
| HT942524P0004 purchase order | $250K | Dha sttr ph i proposal h23b-001-0020 ,topic dha23b-001-0020 title an automated blood-in, mirnas-out assay to detect circulating and exosome mirnas egs 2300543 medical r and d | Defense Health Agency | Health R&D | Oct 4, 2023 DoD 90d |
| HT942524P0034 purchase order | $250K | Dha sttr phase 1 medical research and development purchase order for "proposal h23c-002-0028 "development of woundshield for pseudomonas aeruginosa-caused wounds infections" | Defense Health Agency | Health R&D | Feb 13, 2024 DoD 90d |
| W911QY24P0008 purchase order | $197K | Research and development | Army | Science and technology R&D | Dec 12, 2023 DoD 90d |
| HT942523C0067 definitive contract | $0 | Dha sbir direct to ph ii medical R&D contract awarded from proposal no.-h2d-0119 for "development for shockdefender against hemorrhagic shock" | Defense Health Agency | Health R&D | Apr 16, 2025 DoD 90d |
| HT942523P0041 purchase order | $0 | Zymeron DHA sbir phase i h231-004-0023 novel aerosol therapy for immediate and sustained ards management | Defense Health Agency | Health R&D | Dec 15, 2023 DoD 90d |
| W81XWH22C0012 definitive contract | $0 | Award of zymeron's DHA sbir phase ii medical R&D contract for "development for a novel countermeasure, radiodefender, as a radioprotector for hematopoietic acute radiation syndrome" | Defense Health Agency | Health R&D | Mar 17, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial